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Analysis of Immune Cell Infiltrates during
Squamous Carcinoma Development
Simon R. Junankar1, Alexandra Eichten1, Annegret Kramer1, Karin E. de Visser1,4 and Lisa M. Coussens2,3
Infiltration of leukocytes into tissue is a common feature of many physiological and pathological conditions.
Histopathologically, the diversity of leukocytes that infiltrate a tissue associated with a pathophysiologic
response cannot be appreciated and/or examined unless highly selective immunologic detection methods are
utilized. Specific populations of infiltrating leukocytes into squamous tissues harboring pre-malignant and/or
malignant keratinocytes have recently been demonstrated to play a functionally significant role in the
pathogenesis of squamous carcinomas. To evaluate immune cell types and quantify changes in their relative
presence and localization during multi-stage neoplastic progression, we performed flow cytometry and
histochemical detection using lineage-selective markers. Herein, we provide detailed methodology facilitating
these analyses.
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INTRODUCTION
The immune system can be divided into two subsets based on
antigen specificity and timing of activation, for example, the
innate and the adaptive immune systems. In order to provide
optimal protection against invading pathogens, both subsets
of the immune system are intimately linked. The innate
immune system, also referred to as the first line of immune
defense against infection, is composed of dendritic cells,
macrophages, neutrophils, basophils, eosinophils, mast cells,
natural killer cells, and soluble complement components,
and is relatively nonspecific and not intrinsically affected by
prior contact with infectious agents. Some innate immune
cells, for example, dendritic cells, macrophages, and mast
cells, serve as sentinel cells, that is, they are pre-stationed in
tissues and continuously monitor their microenvironment for
signs of distress. When tissue homeostasis is perturbed,
sentinel macrophages and mast cells instantly release soluble
mediators, for example, cytokines, chemokines, matrix remo-
deling proteases, reactive oxygen species, and bioactive
mediators such as histamine, that induce mobilization and
infiltration of additional leukocytes into damaged tissue
(inflammation) as well as activate vascular and fibroblast
responses in order to orchestrate elimination of invading
organisms and initiate local tissue repair. Dendritic cells, on
the other hand, take up foreign antigens and migrate to
lymphoid organs where they present their antigens to
adaptive immune cells, thus representing key players in the
interface between innate and adaptive immunity.
The adaptive immune system (also called the acquired
immune system) distinguishes itself from the innate immune
system by its antigen specificity and memory formation.
Adaptive immune cells, for example, B lymphocytes, CD4þ
(helper) T lymphocytes, and CD8þ (cytotoxic) T lymphocytes,
express somatically generated, diverse antigen-specific recep-
tors, formed as a consequence of random gene rearrange-
ments. As individual B and T lymphocytes are antigenically
committed to a specific unique antigen, clonal expansion
upon recognition of foreign antigens is required to obtain
sufficient antigen-specific T and/or B lymphocytes to counter-
act infection. Together, acute activation of these distinct
immune response pathways results in removal of invading
organisms, ‘‘damaged’’ cells, and extracellular matrix, and
enables subsequent normalization of cell proliferation and cell
death pathways, allowing re-establishment of tissue integrity
and homeostasis. Owing to their enormous plasticity, immune
cells exert multiple effector functions that are continuously
fine-tuned as tissue microenvironments are altered; thus, the
immune system is integrally involved in maintaining tissue
homeostasis as well as being implicated in the pathogenesis of
many chronic diseases including arthritis, heart disease,
Alzheimer’s disease, and cancer (Finch and Crimmins, 2004;
de Visser et al., 2006).
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Because a diverse assortment of immune cell types
infiltrate neoplastic tissues, we have investigated their unique
profiles during multi-stage neoplastic progression utilizing
a transgenic mouse model of epithelial carcinogenesis,
for example, K14-HPV16 (human papillomavirus type 16)-
transgenic mice (Coussens et al., 1996). HPV16 mice express
the early region genes of HPV16 as transgenes under control
of the human keratin 14 promotor/enhancer (Arbeit et al.,
1994). By 1 month of age, HPV16 mice develop epidermal
hyperplasias with 100% penetrance characterized by a
terminally differentiating hyperproliferative epidermis.
Hyperplastic lesions advance focally into angiogenic dyspla-
sias between 3 and 6 months of age and are distinct from
hyperplasias based upon the prominent hyperproliferative
epidermis that fails to undergo terminal differentiation and a
dermis where intense CD45þ leukocyte infiltration occurs
proximal to dilated and enlarged angiogenic vasculature
(Coussens et al., 1999; van Kempen et al., 2002). By 1 year of
age, 60% of HPV16 mice develop malignant skin carcino-
mas, 50% of which are squamous-cell carcinomas (SCCs)
that metastasize to regional lymph nodes with a B30%
frequency, and B10% of which represent non-metastatic
microcystic adnexal carcinomas (van Kempen et al.,
2002; Rhee et al., 2004). This genetic model of squamous
carcinogenesis has proven useful as a tool with which to
assess functional significance of specific infiltrating immune
cell types (Coussens et al., 1999, 2000; Daniel et al., 2003,
2005; Giraudo et al., 2004; de Visser et al., 2005) that
regulate de novo epithelial carcinogenesis.
RESULTS
Experimental analysis of distinct leukocyte populations in
tissues where cellular heterogeneity progressively changes
owing to physiologic or pathologic assault/damage is aided
by examining immunoreactivity of lineage-selective epitopes
in either single-cell suspensions or alternatively in tissue
sections. Here, we used a transgenic mouse model of
epithelial carcinogenesis and qualitatively and quantitatively
examined changes in the relative presence and localization
of various innate and adaptive leukocytes, for example,
mast cells, granulocytes (neutrophils), monocytes, macro-
phages, and B and T lymphocytes, at each stage of neoplastic
progression. Single-cell suspensions from wild-type (wt) and
neoplastic skin were analyzed by flow cytometry using
antibodies for lineage-selective epitopes to assess immune
cell populations expressing CD45, CD11-b, GR-1, F4/80,
CD4, CD8, and CD19/B220. To complement these studies,
paraffin-embedded tissue sections were used to discern
changes in localization and/or abundance of CD45þ
leukocytes, GR-1þ neutrophils, F4/80þ or colony stimulat-
ing factor-1 receptor (CSF-1R)þ macrophages, and serine
esterase-positive mast cells.
Figure 1 shows representative histograms representing
flow cytometry analyses assessing leukocyte presence in
single-cell suspensions of ear skin removed from wt
mice versus dysplastic ear skin from HPV16 mice, for
example, CD45þ , CD11-bþ , GR-1þ , F4/80þ , CD4þ ,
CD8þ , and CD19/B220þ . CD45 (leukocyte common
antigen) is expressed by all hematopoietic lineages (Trow-
bridge and Thomas, 1994), and is also expressed in fibrocytes
from peripheral blood (Abe et al., 2001). In contrast, CD11b/
MAC-1 is a cell surface beta(2)-integrin selectively expressed
on neutrophils, monocytes, natural killer cells, and some
lymphocytes (Myones et al., 1988). GR-1 is expressed on
myeloid cells but not on lymphoid or erythroid cells and
increases with granulocyte maturation (Fleming et al., 1993).
F4/80 is well known as a highly restricted macrophage
molecule in mice (Austyn and Gordon, 1981). T lymphocytes
were identified by their expression of the CD4 or CD8
co-receptors (Mathieson and Fowlkes, 1984; Scollay et al.,
1984), whereas B lymphocytes were identified by their dual
immunoreactivity for CD19 and B220 (Li et al., 1996).
Quantitative comparisons of leukocyte infiltrations in wt skin
versus hyperplastic and dysplastic skin and carcinomas in
HPV16 mice are shown in Figure 1c.
Immunohistochemical (IHC) detection of leukocytes was
employed to ascertain their spatial–temporal distributions in
wt and neoplastic tissue from HPV16 mice (Figures 2–4).
CD45þ cells were predominately located within dermal
stroma below the epithelial basement membrane in wt and
pre-malignant tissue, with only occasional CD45þ cells
present within the epidermis (Figure 2a–c). In carcinomas, a
uniform presence of CD45þ cells was observed throughout
tumor stroma (Figure 1).
Chloroacetate esterase histochemistry is a useful enzy-
matic histochemical approach to evaluate presence of serine
esterases in mast cells and neutrophils (Leder, 1979). The
difficulty with this approach is that when both mast cells and
neutrophils are present within a tissue, traditional chloro-
acetate esterase (Leder, 1979) will not accurately delineate
between the serine esterase activities in mast cells (chymase)
as opposed to that found in neutrophils (neutrophil elastase).
To accomplish this and to visualize chymase activity present
in mast cells more selectively, we employed a modification of
the chloroacetate esterase method on paraffin-embedded
tissue sections (blue staining; Figure 3a) as compared to IHC
detection of granulocytes with a neutrophil-specific anti-
body (brown staining; Figure 3b). Individual mast cells were
identified in wt dermal stroma, whereas GR-1þ neutrophils
were absent. In pre-malignant tissue, similar localization of
mast cells and GR-1þ neutrophils was revealed. Whereas
infiltrates of Gr-1þ neutrophils were prominent in carci-
nomas at the leading edges (SCC-LE) as well as tumor
centers (SCC-C), mast cells were only modestly associated
with invasive fronts and almost completely absent in tumor
centers. Whereas flow cytometric analysis of analogous
single-cell suspensions generated from wt and/or neoplastic
tissue revealed that GR-1þ neutrophils were predominately
found in dysplastic and carcinoma tissue (Figure 1d),
individual counting of positively stained cells in micrographs
by contrast revealed a significant increase in GR-1þ cell as
early as the hyperplastic stage (Figure 3b). This disparity
reflects one benefit of micrograph quantitation where distinct
cell types can be examined independently of other cellular
populations as opposed to reflecting their percentage of the
total number of cells counted in the suspension.
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Definitive identification of macrophages during neoplastic
progression in HPV16 mice has proven difficult. Several well-
characterized macrophage-selective markers have been
identified and used for flow cytometry and/or IHC detection
of macrophages in other organ contexts, for example, Mac-1,
Mac-2 (galectin-3), CD68 (microsialin), and F4/80 (Lin et al.,
2001; Giraudo et al., 2004; Inoue et al., 2005). F4/80 is well
known as a highly restricted macrophage molecule in mice
(Austyn and Gordon, 1981). Moreover, several lines of
evidence indicate that the macrophage growth factor CSF-1
is required for macrophage differentiation acting through the
CSF1-R expressed on macrophages (Lin et al., 2002). Using
F4/80 and CSF1-R antibodies to visualize macrophage
presence in wt and neoplastic tissue sections, we found that
both F4/80þ and CSF1-Rþ cells increased in presence during
neoplastic progression as evidenced by IHC detection;
however, their respective staining patterns were distinct.
Moreover, histochemical analysis indicates a prominent F4/
80þ cellular population that increases in presence during
neoplastic progression, a population that is not identified by
flow cytometry. Sasmono et al. (2003) have reported that all
CSF-1Rþ cells are also F4/80þ in unchallenged mice. If this
is correct, this would indicate that during skin carcinogenesis
in HV16 mice, disregulation of these markers occurs. It is
Figure 1. Flow cytometric analysis of leukocytes during neoplastic progression in HPV16 mice. (a) Single-cell suspensions derived from ear-tissue from
negative littermate ()LM wt and ear-tissue from HPV16 mice were analyzed by flow cytometry to determine the percentage of positively stained cells
as a percentage of total viable cells after gating on forward and side scatter and subsequent gating on live cells by exclusion of 7AAD-positive cells.
(b, c) Representative histograms for CD45, CD11b, GR-1, and F4/80, and dot blots for CD4-, CD8-, and CD19/B220-positive cells are shown reflecting ()LM
versus dysplastic HPV16 skin. (d) Quantitative analysis reflecting presence of CD45-, CD11b-, GR-1-, F4/80-, CD4-, CD8-, and CD19/B220-positive cells in
single-cell suspensions derived from the skin of ()LMs and pre-malignant (hyperplastic, dysplastic) skin and carcinomas from HPV16 mice was determined as a
percentage of total viable cells. Results shown are mean percentages (n¼3–7 mice). Error bars represent SEM.
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interesting to note that F4/80þ and neutrophil markers in the
skin demonstrate similar staining patterns, as assessed
by IHC. Huang et al. (2006) recently reported that a subset
of Gr-1þ cells located in the spleen of tumor-bearing mice
also expressed the macrophage markers F4/80 and CSF-1R,
and also defined these cells as a more potent subset of
myeloid suppressor cells. The biological implications of this
cell type and more definitive analysis of their presence in
HPV16 skin require further investigation.
DISCUSSION
A functional link between inflammation and cancer has been
suspected for many years (Balkwill and Mantovani, 2001;
Coussens and Werb, 2002). Initially, it was believed that
leukocytic infiltrates in and around developing neoplasms
represented an attempt of the host to eradicate neoplastic
Figure 2. CD45 immunostaining during neoplastic progression. (a–f)
Immunodetection of CD45-positive leukocytes (brown staining) in
paraffin-embedded sections of staged neoplastic tissue reveals
incremental increases in the number of CD45-positive leukocytes in the
successive neoplastic stages. e, Epidermis; d, dermis; c, cartilage; f, hair
follicle. Bar¼ 50mm.
Figure 3. Infiltration of neoplastic skin by mast cells and granulocytes.
(a) Mast cells (blue staining) in ()LM and pre-malignant skin and carcinomas
of HPV16-transgenic mice. (b) Immunostaining for GR-1þ granulocytes
(neutrophils) in ()LM and pre-malignant skin and carcinomas of
HPV16-transgenic mice. Graphical representation of mast cell and GR-1þ
neutrophil staining averaged from five high-power fields per mouse and five
mice per category. Error bars represent SEM and asterisk (*) indicates
statistically significant differences between HPV16 and wt (Po0.05
Mann–Whitney). e, epidermis; d, dermis; c, cartilage; f, hair follicle; SCC (C),
central region of carcinoma; SCC(LE), leading edge of carcinoma.
Bar¼50 mm.
Figure 4. Distinct characteristics of F4/80þ versus CSF-1Rþ macrophages
during neoplastic progression. Macrophages were visualized by
immunoreactivity to either F4/80 (a–c, g) or CSF-1-R (d–f, h) in ()LM and
pre-malignant skin and carcinomas of HPV16-transgenic mice. Higher
magnification images are shown in panels i–l representing F4/80, CSF-1-R,
GR-1, or mast cell staining at the leading edge of the carcinomas shown in
g and h. e, epidermis; d, dermis; c, cartilage; f, hair follicle. Bar¼50 mm.
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cells. Indeed, extensive infiltration of natural killer cells in
human gastric or colorectal carcionoma is associated with a
favorable prognosis (Coca et al., 1997; Ishigami et al., 2000).
On the other hand, malignant tissues containing infiltrates of
other innate immune cell types such as macrophages in
human breast carcinoma and mast cells in human lung
adenocarcionoma and melanoma tend to correlate with an
unfavorable clinical prognosis (Leek et al., 1996, 1999;
Imada et al., 2000; Ribatti et al., 2003). Moreover, popula-
tion-based studies reveal that individuals prone to chronic
inflammatory diseases exhibit enhanced risk for cancer
development (Balkwill et al., 2005), whereas long-term use
of non-steroidal anti-inflammatory drugs reduces the risk
of several cancer types (Balkwill and Mantovani, 2001;
Coussens and Werb, 2002; Balkwill et al., 2005).
How then do chronically activated innate immune cells
participate in cancer development? Which mechanisms and
which inflammatory cell-derived mediators are relevant for
specific human malignancies, are these organ-, tumour stage,
or etiology-dependent? Many of these questions remain
unanswered; however, experimental models are beginning
to elucidate molecular mechanisms by which innate immune
cells regulate cancer processes (de Visser et al., 2006).
Because of their enormous plasticity and capacity to
produce a myriad of cytokines, chemokines, metallo-serine
and cystein proteases, reactive oxygen species, histamine,
and other bioactive mediators, chronically activated innate
immune cells are key modulators of cell survival (prolifera-
tion and cell death) as well as regulators of extracellular
matrix metabolism. Thus, several physiological processes
necessary for tumor development, such as enhanced cell
survival, tissue remodeling, angiogenesis, and suppression
of antitumor adaptive immune responses, are regulated
by leukocytic infiltrates in neoplastic environments. This is
exemplified by positive correlations between numbers of
innate immune cells (macrophages, mast cells, and granulo-
cytes) infiltrating human tumors with the number of blood
vessels (Yano et al., 1999; Esposito et al., 2004) and
experimental findings in mouse models where attenuating
innate immune cell infiltration of pre-malignant tissue
reduces angiogenesis and limits tumor development
(Coussens et al., 1999; Sparmann and Bar-Sagi, 2004; de
Visser et al., 2005).
We and others have utilized the K14-HPV16 mouse model
of epithelial carcinogenesis (Arbeit et al., 1996; Coussens
et al., 1996) to evaluate profiles of immune cells present
during neoplastic progression in skin and cervix via IHC
detection methods in tissue sections and/or by flow cytometry
(Figures 1–4) (Coussens et al., 1999, 2000; van Kempen
et al., 2002; Giraudo et al., 2004; de Visser et al., 2005).
Interestingly, the profile of infiltrating inflammatory cells in
skin is distinct as compared to cervix – pre-malignant skin
lesions contain infiltrating mast cells, CD11bþ , GR-1þ , and
F4/80þ cells predominantly (Coussens et al., 1999; de Visser
et al., 2005), whereas pre-malignant cervical lesions are
characterized by infiltrating F4/80þ macrophages (Giraudo
et al., 2004), and neither are characterized by significant
infiltration of T or B lymphocytes (de Visser et al., 2005).
With the aid of the methodologies described in this report
allowing for accurate characterization of immune cell
presence in neoplastic tissue, we hypothesized that innate
immune cells were potentiating cancer development. To
address this hypothesis, we generated mast cell-deficient/
HPV16 mice and found attenuated neoplastic development
largely owing to reduced activation of angiogenic vasculature
and a failure of keratinocytes to achieve hyperproliferative
growth characteristics (Coussens et al., 1999), indicating that
activation and/or degranulation of immune cells in neoplastic
tissue shifts a critical balance that promotes cancer develop-
ment. More significantly, studies such as these indicate that
limiting or altering presence of pro-tumor innate immune cells
in pre-malignant tissue minimizes oncogene-induced primary
cancer development. More recently, we found that genetic
deletion of the complete adaptive immune system in HPV16
mice resulted in a failure to initiate chronic inflammation
during pre-malignancy, resulting in attenuated pre-malignant
progression and reduced carcinoma incidence (de Visser
et al., 2005). Transfer of B lymphocytes or serum isolated from
K14-HPV16 mice into adaptive immune-deficient/K14-
HPV16 mice restored chronic inflammation in neoplastic
skin as well as hallmarks of pre-malignant progression (de
Visser et al., 2005), indicating that B lymphocytes play a
crucial role in the onset of chronic inflammation associated
with pre-malignant progression, thus potentiating neoplastic
cascades downstream of oncogene expression.
Tumor-promoting roles for innate immune cells down-
stream of oncogene expression have also been described in
other experimental tumor models (Lin et al., 2001; Sparmann
and Bar-Sagi, 2004). Lin et al. (2001) studied the role of CSF-1
during mammary carcinoma development by comparing
transgenic mice susceptible to de novo development of
mammary carcinomas (PyMT mice) with CSF-1-deficient
PyMT mice (PyMT/Csf1op/op). Whereas absence of CSF-1
during early neoplastic development was without apparent
consequence, development of late-stage invasive carcinomas
and pulmonary metastases was significantly attenuated in
PyMT/Csf1op/op mice, and correlated with a failure to recruit
mature macrophages into neoplastic tissue in the absence of
CSF-1. Macrophage recruitment was restored by transgenic
CSF-1 expression in mammary epithelium in PyMT/Csf1op/op
mice, as was characteristic primary and metastatic
tumor development (Lin et al., 2001). Together, these studies
indicate that the biological effect of tumor-infiltrating innate
immune cells depends on the local levels of proinflammatory
cytokines and numbers of innate immune cells in the
neoplastic microenvironment (Nesbit et al., 2001). Immature
myeloid cells or myeloid suppressor cells are a hetero-
geneous cell population characterized as CD11b/Gr-1
double-positive cells that typically differentiate into mature
macrophages, neutrophils, or dendritic cells (Kusmartsev and
Gabrilovich, 2006; Serafini et al., 2006) that can inhibit
antitumor T-cell function and T-lymphocyte proliferation
and promote development of regulatory T cells (Huang et al.,
2006). They have also been shown to have a direct pro-tumor
role by secreting molecules like matrix metalloproteinase-9,
an important regulator of extracellular matrix remodeling and
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vascular endothelial growth factor bioavailability (Yang et al.,
2004). The initiation of myeloid suppressor cell differentia-
tion cascades and/or their differential presence within
neoplastic tissue could be an important feature of chronic
inflammation that potentiates tumor development as opposed
to chronic inflammatory scenarios such as exists in psoriatic
lesions where cancer development is not a favored outcome.
Mouse cancer models like K14-HPV16 mice provide
invaluable insights into the diverse role immune cells play
during cancer development. Utilizing the power of IHC
detection of specific immune cell types in tissue sections or
as quantified in single-cell suspensions by flow cytometry,
routine access to staged pre-malignant and malignant tissues
provides a unique opportunity to evaluate variances in immune
cell infiltration and to define functionally significant roles for
their presence in that tissue. Identifying and characterizing
novel and robust markers for distinct immune cell types that
infiltrate neoplastic microenvironments will enhance future
investigations regarding the exact profile of immune cell types
that are present in assessed tissue. Using such markers to
visualize and quantify distinct immune cell populations during
skin carcinogenesis has provided an insight into the role
chronic inflammation plays during cancer development.
MATERIALS AND METHODS
Transgenic mice
Generation and characterization of HPV16-transgenic mice and
neoplastic staging based on keratin intermediate filament expression
has been described previously (Arbeit et al., 1994; Coussens et al.,
1996). All mice were maintained within the UCSF Laboratory for
Animal Care facility according to the IACUC procedures.
Flow cytometry
Leukocytic infiltrates in neoplastic tissues were analyzed by flow
cytometry. Single-cell suspensions were prepared from ears of
negative littermate (()LM) wt FVB/n mice or ears and/or carcinomas
from HPV16 mice at specific ages reflecting distinct stages of
neoplastic progression as reported previously (Coussens et al., 1996,
1999, 2000; de Visser et al., 2004, 2005). Single-cell suspensions
were prepared by mincing tissue with scissors, followed by a
13-minute enzymatic digestion with 2.5 mg/ml collagenase Type II
(Worthington, Lakewood, NJ), 2.5 mg/ml collagenase Type IV
(Gibco, Carlsbad, CA), and 0.5 mg/ml DNase (Sigma, St Louis,
MO) in phosphate-buffered saline (PBS) containing 1% BSA (Sigma)
(PBS/BSA) at 371C under continuous stirring conditions. Digests were
quenched by adding DMEM (Gibco) containing 10% fetal bovine
serum (Gibco) and subsequently filtered through a 70-mm nylon filter
(Falcon, BD Biosciences, San Jose, CA). Single-cell suspensions were
treated with PharM Lyse ammonium chloride lysing reagent (BD
Biosciences, San Diego, CA) for 5 minutes to remove erythrocytes.
Cells were washed with DMEM containing 10% fetal bovine serum,
followed by washing with PBS/BSA. Cells were incubated for
10 minutes at 41C with rat anti-mouse CD16/CD32mAb (clone
2.4G2, BD Biosciences) at a 1:200 dilution in PBS/BSA to prevent
nonspecific antibody binding. Subsequently, cells were washed
and incubated for 20 minutes with 50ml of 1:200 dilution of
allophycocyanin-conjugated anti-mouse CD45 (clone 30-F11,
eBioscience, San Diego, CA), FITC-conjugated anti-mouse GR-1
(Ly-6G, clone RB6-8C5, eBioscience), phycoerythrin-conjugated anti-
mouse CD31 (clone MEC13.3, BD Biosciences), FITC-conjugated
anti-mouse CD4 (L3T4, clone GK1.5, eBioscience), phycoerythrin-
conjugated anti-mouse CD8a (L-2, clone 53-6.7, eBioscience),
allophycocyanin-conjugated anti-mouse CD19 (clone MB19.1,
eBioscience), FITC-conjugated anti-mouse B220 (clone RA3-6B2,
eBioscience), phycoerythrin-conjugated anti-mouse F4/80 (clone
CI:A3-1, Caltag Laboratories, Burlingame, CA), and phycoerythrin-
conjugated anti-mouse CD11b (clone M1/70, BD Biosciences Phar-
mingen, San Jose, CA). Cells were washed twice with PBS/BSA and
7-AAD (BD Biosciences) was added at a dilution of 1:10 to discriminate
between viable and dead cells. Data acquisition was performed on a
FACSCalibur using CellQuestPro software (BD Biosciences) and data
analysis was performed using FlowJo software (Tree Star Inc.). Gates
were set using negative controls and positive populations were
corrected by subtraction of background and nonspecific binding of
the antibody. Data shown as bar graphs as the mean7SEM reflecting a
minimum of five mice per respective histopathologic stage.
Tissue immunostaining and enzyme histochemistry
Age-matched tissue samples from transgenic and control animals
were immersion-fixed in 10% neutral-buffered formalin followed
by dehydration through graded alcohols and xylene and then
embedded in paraffin. Paraffin sections (5-mm-thick) were cut using a
Leica 2135 microtome. Sections were deparaffinized and subjected
to enzyme and IHC detection.
Modified chloroacetate esterase histochemistry was performed
to visualize chymase-like activity in mast cells. A 1 mg portion of
naphthol AS-D chloroacetate (Sigma) was dissolved in 20 ml of N,
N-dimethyl formamide (Sigma) and 1 ml buffer (8% N,N-dimethyl
formamide, 20% ethylene glycol monoethylether in 80 mM
Tris-maleate pH 7.5). Subsequently, 1 mg Fast Blue BB salt (Fluka,
Buchs, Switzerland) was added, the solution filtered using a 0.45 mm
filter, and then applied to deparaffinized paraffin sections for
5 minutes. Sections were rinsed in PBS, dehydrated through graded
alcohols, and mounted in glycerol.
IHC on paraffin sections was performed to visualize cells of
hematopoietic origin using rat anti-mouse CD45 (Ly-5, clone
30-F11, BD Biosciences Pharmingen), macrophages using rat
anti-mouse F4/80 (clone CI:A3-1, Serotec, Raleigh, NC) or rabbit
anti-mouse CSF-1R (catalog no. 06-174, Upstate, Charlottesville,
VA), and granulocytes using a rat anti-mouse neutrophil-specific
primary antibody (clone 7/4, Cedarlane Labs, Hornby, Ontario,
Canada). Antigens were retrieved by proteinase K (DAKO,
Carpinteria, CA) treatment for 3 minutes for the macrophage and
neutrophil stainings. Sections were blocked in blocking buffer (5%
goat serum/2.5% BSA/PBS) for 30 minutes. Primary antibodies were
diluted in 0.5 blocking buffer at 1:5,000 F4/80, and 1:500 for the
CD45-, CSF-1R-, and the neutrophil-specific antibody. Sections were
incubated with primary antibody for 1–4 hours at room temperature,
followed by PBS washing, brief (5 minutes) incubation in blocking
buffer and subsequent incubation with biotinylated secondary
antibody (rabbit anti-rat IgG 1:200, Vector, Burlingame, CA; except
for CSF-1R, which used goat anti-rabbit IgG 1:200, Pierce, Rockford,
IL) for 45 minutes at room temperature. Sections were then washed
in PBS and endogenous peroxidase activity blocked by incubation in
0.6% H2O2 in methanol for 20 minutes. For the CSF-1R, CD45, and
neutrophil stainings after PBS washing, Vectastain Elite ABC reagent
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(Vector) was applied for 30 minutes. For the F4/80 stainings after the
peroxide treatment and PBS washing, streptavidin-horseradish
peroxidase (Perkin Elemer, Wellesley, MA) was applied for
30 minutes, biotinyl tyramide (Perkin Elmer) was then applied for
7 minutes, followed by streptavidin-horseradish peroxidase for a
further 30 minutes. Antibodies were visualized by treatment with
Fast 3,30-diaminobenzidine (Sigma), counterstained with methyl
green (1% in H2O), dehydrated in isobutanol, cleared in xylene, and
mounted in Cytoseal 60 (Richard-Allan Scientific, Kalamazoo, MI).
All immunolocalization experiments were repeated on multiple
tissue sections and included negative controls for determination of
background staining, which was negligible. Data shown are
representative of results obtained following examination of tissues
removed from a minimum of five different mice per distinctive stage
(or age) of neoplastic progression. Quantitative analysis of labeled
cells was performed by counting cells in five random high-power
fields (40) per age-matched tissue section from five mice per group.
Data presented reflect the mean total cell count per field from the
ventral ear leaflet for wt and pre-malignant tissues, carcinoma
centers, or carcinoma leading edge.
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